Gentian Diagnostics ASA (OSL:GENT)
Norway · Delayed Price · Currency is NOK 39.20
+0.70 (1.82%)
Oct 13, 2026, 4:25 PM CET
Gentian Diagnostics ASA Ratios and Metrics
Market cap in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 606 | 870 | 605 | 640 | 632 | 1,110 | |
Market Cap Growth | -25.86% | 43.88% | -5.54% | 1.22% | -43.06% | 32.20% |
Enterprise Value | 543 | 785 | 517 | 574 | 555 | 1,000 |
Last Close Price | 38.50 | 55.64 | 38.36 | 40.61 | 40.12 | 70.46 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 65.62 | 13.35 | - | - | - |
Forward PE | 26.37 | 29.00 | 28.52 | - | - | - |
PS Ratio | 3.27 | 4.93 | 3.98 | 4.74 | 5.65 | 11.10 |
PB Ratio | 3.26 | 4.24 | 3.12 | 4.37 | 4.10 | 6.35 |
P/TBV Ratio | 3.34 | 5.14 | 3.65 | 5.10 | 4.97 | 7.42 |
P/FCF Ratio | 32.57 | 21.02 | 50.05 | 44.13 | - | - |
P/OCF Ratio | 30.87 | 20.42 | 44.93 | 41.40 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.92 | 4.45 | 3.40 | 4.24 | 4.96 | 10.00 |
EV/EBITDA Ratio | 17.89 | 27.53 | 27.82 | - | - | - |
EV/EBIT Ratio | 23.26 | 30.85 | 32.91 | - | - | - |
EV/FCF Ratio | 29.15 | 18.97 | 42.83 | 39.55 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.09 | 0.11 | 0.05 | 0.09 | 0.10 | 0.11 |
Debt / EBITDA Ratio | 0.56 | 0.71 | 0.45 | - | - | - |
Debt / FCF Ratio | 0.92 | 0.56 | 0.83 | 0.90 | - | - |
Net Debt / Equity Ratio | -0.34 | -0.40 | -0.38 | -0.51 | -0.43 | -0.55 |
Net Debt / EBITDA Ratio | -2.41 | -2.91 | -4.02 | 7.54 | 3.24 | 4.52 |
Net Debt / FCF Ratio | -3.42 | -2.00 | -6.18 | -5.14 | 2.93 | 3.43 |
Asset Turnover | 0.80 | 0.72 | 0.74 | 0.73 | 0.56 | 0.45 |
Inventory Turnover | 1.54 | 1.57 | 1.67 | 1.87 | 1.54 | 1.71 |
Quick Ratio | 5.20 | 3.81 | 3.85 | 4.13 | 4.58 | 6.10 |
Current Ratio | 7.43 | 5.40 | 5.38 | 5.60 | 6.33 | 7.42 |
Return on Equity (ROE) | -4.42% | 6.64% | 26.59% | -7.08% | -14.36% | -13.43% |
Return on Assets (ROA) | 6.30% | 6.52% | 4.78% | -4.32% | -7.27% | -6.39% |
Return on Invested Capital (ROIC) | 19.81% | 10.89% | 16.43% | -15.96% | -27.94% | -33.28% |
Return on Capital Employed (ROCE) | 11.50% | 11.30% | 7.90% | -8.20% | -14.00% | -12.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -1.41% | 1.52% | 7.49% | -1.66% | -3.74% | -2.23% |
FCF Yield | 3.07% | 4.76% | 2.00% | 2.27% | -3.57% | -2.53% |
Dividend Yield | 1.53% | 1.08% | 1.04% | - | - | - |
Payout Ratio | - | 46.54% | - | - | - | - |
Buyback Yield / Dilution | 3.33% | 1.73% | -2.21% | - | -0.04% | -0.07% |
Total Shareholder Return | 4.88% | 2.81% | -1.16% | - | -0.04% | -0.07% |